Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5IXA

HCMV DNA polymerase processivity subunit UL44 at neutral pH and low salt

5IXA の概要
エントリーDOI10.2210/pdb5ixa/pdb
関連するPDBエントリー1T6L 1YYP 5IWD
分子名称DNA polymerase processivity factor (2 entities in total)
機能のキーワードhcmv pol accessory subunit, protein-protein interaction, human cytomegalovirus, dna polymerase, processivity factor, replication
由来する生物種Human cytomegalovirus (strain AD169) (HHV-5)
タンパク質・核酸の鎖数2
化学式量合計65153.01
構造登録者
Chen, H.,Coen, D.M.,Hogle, J.M.,Filman, D.J. (登録日: 2016-03-23, 公開日: 2016-11-30, 最終更新日: 2023-09-27)
主引用文献Chen, H.,Coseno, M.,Ficarro, S.B.,Mansueto, M.S.,Komazin-Meredith, G.,Boissel, S.,Filman, D.J.,Marto, J.A.,Hogle, J.M.,Coen, D.M.
A Small Covalent Allosteric Inhibitor of Human Cytomegalovirus DNA Polymerase Subunit Interactions.
ACS Infect Dis, 3:112-118, 2017
Cited by
PubMed Abstract: Human cytomegalovirus DNA polymerase comprises a catalytic subunit, UL54, and an accessory subunit, UL44, the interaction of which may serve as a target for the development of new antiviral drugs. Using a high-throughput screen, we identified a small molecule, (5-((dimethylamino)methylene-3-(methylthio)-6,7-dihydrobenzo[c]thiophen-4(5H)-one), that selectively inhibits the interaction of UL44 with a UL54-derived peptide in a time-dependent manner, full-length UL54, and UL44-dependent long-chain DNA synthesis. A crystal structure of the compound bound to UL44 revealed a covalent reaction with lysine residue 60 and additional noncovalent interactions that cause steric conflicts that would prevent the UL44 connector loop from interacting with UL54. Analyses of the reaction of the compound with model substrates supported a resonance-stabilized conjugation mechanism, and substitution of the lysine reduced the ability of the compound to inhibit UL44-UL54 peptide interactions. This novel covalent inhibitor of polymerase subunit interactions may serve as a starting point for new, needed drugs to treat human cytomegalovirus infections.
PubMed: 28183184
DOI: 10.1021/acsinfecdis.6b00079
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.684 Å)
構造検証レポート
Validation report summary of 5ixa
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon